Procare Health released results from their latest clinical trial, Paloma 2, confirming the efficacy of Papilocare®, a vaginal gel designed to repair low-grade cervical lesions and to clear Human Papillomavirus
Published on 08/07/2025 at 18:03 | prnewswire.co.uk
en | boerse | 68000181 |
